In vitro process for diagnosis of disease risks

Details In vitro process for diagnosis of disease risks In vitro process for diagnosis of disease risks

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) C12N 15/12 (2006.01) C07K 14/47 (2006.01)

Patent

CA 2610134

The invention relates to the use of a genomic gene modification in the gene for the G.alpha.11 subunit of human G--proteins which subunit is encoded by the gene GA11, for the prognosis of disease risks, disease developments and the response to disease therapies by pharmacological and non--pharmacological measures and for predicting undesired drug effects. The invention relates moreover to the provision of individual gene modifications and haplotypes by means of which further gene modifications suitable for use for the above--mentioned purposes can be detected and validated. Such gene modifications may consists of a G(-659)C polymorphism being detected in the promoter of the gene. The gene modifications can be detected individually or in any desired combination by means of processes familiar to the expert.

Affiliated with

Also associated with

Rating

In vitro process for diagnosis of disease risks does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In vitro process for diagnosis of disease risks, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro process for diagnosis of disease risks will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1497010